|
|
Volumn 14, Issue 11, 1996, Pages 1549-1554
|
|
New Treatments for Acute Stroke: A Better Understanding of What Actually Happens in Ischemic Brain Events is Leading to Therapies that Limit Permanent Brain Damage
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALTEPLASE;
ANCROD;
ANTIINFLAMMATORY AGENT;
APTIGANEL;
CALPAIN;
CITICOLINE;
FOSPHENYTOIN SODIUM;
HEPARIN;
INTEGRIN ANTIBODY;
INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY;
LUBELUZOLE;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;
NIMODIPINE;
SCAVENGER;
TIRILAZAD;
UNCLASSIFIED DRUG;
CARDIOTOXICITY;
CLINICAL TRIAL;
DRUG EFFICACY;
FIBRINOLYTIC THERAPY;
HALLUCINATION;
HUMAN;
MIDDLE CEREBRAL ARTERY OCCLUSION;
PRIORITY JOURNAL;
PROGNOSIS;
REVIEW;
RISK ASSESSMENT;
STROKE;
TRANSIENT ISCHEMIC ATTACK;
TREATMENT PLANNING;
BRAIN;
CEREBROVASCULAR CIRCULATION;
CEREBROVASCULAR DISORDERS;
HOMEOSTASIS;
HUMANS;
ISCHEMIC ATTACK, TRANSIENT;
MAGNETIC RESONANCE IMAGING;
MALE;
MICROCIRCULATION;
MIDDLE AGED;
NEURONS;
PLASMINOGEN ACTIVATORS;
TISSUE PLASMINOGEN ACTIVATOR;
|
|
EID: 0029908662
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1196-1549 Document Type: Article |
|
Times cited : (24)
|
|
References (3)
|
